RecruitingNot Applicable

Multimodal Program for Cancer Related Cachexia Prevention

Cyprus60 participantsStarted 2020-09-24

Plain-language summary

The aim of the study is to evaluate the effectiveness of a multifactorial education and support program for the prevention of cancer-related cachexia syndrome, for patients and their family caregivers during anti-cancer treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years old or older
✓. Participants must be diagnosed with solid tumour (stomach, colorectal, pancreas, breast, lung)
✓. Participants needing chemotherapy/immunotherapy/hormone therapy/target therapy
✓. Participants must be normal or pre cachectic as defined by the guidelines
✓. Read and understand Greek or English

Exclusion criteria

✕. Haematologic tumors
✕. Parenteral Nutrition
✕. ECOG Performance status \>2 or Karnofsky Performance Status \<60%
✕. Participant who can not introduce a family caregiver
✕. Participants in cachexia or refractory cachexia stage as defined by the guidelines below:
✕. Patients who use complementary therapies (ex-acupuncture)

What they're measuring

Change from baseline in pre-cachexia stage against cachexia criteria at 12 weeks

Timeframe: Baseline and week 4, week 8, week 12

Trial details

NCT IDNCT04627376

SponsorCyprus University of Technology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02

Contact for this trial

Andreas Charalambous, PhD

00357-25002011 andreas.charalambous@cut.ac.cy

View on ClinicalTrials.gov More Neoplasms trials